These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 21215698)

  • 21. Organ-protective effect of angiotensin-converting enzyme 2 and its effect on the prognosis of COVID-19.
    Cheng H; Wang Y; Wang GQ
    J Med Virol; 2020 Jul; 92(7):726-730. PubMed ID: 32221983
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-Acetyl-Seryl-Asparyl-Lysyl-Proline regulates lung renin angiotensin system to inhibit epithelial-mesenchymal transition in silicotic mice.
    Li S; Li Y; Zhang Y; Li S; Zhang M; Jin F; Wei Z; Yang Y; Gao X; Mao N; Ge X; Xu H; Yang F
    Toxicol Appl Pharmacol; 2020 Dec; 408():115255. PubMed ID: 33007385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Magnolol ameliorates pneumonectomy and monocrotaline-induced pulmonary arterial hypertension in rats through inhibition of angiotensin II and endothelin-1 expression.
    Chang H; Chang CY; Lee HJ; Chou CY; Chou TC
    Phytomedicine; 2018 Dec; 51():205-213. PubMed ID: 30466619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of angiotensin-converting enzyme and angiotensin II in development of hypoxic pulmonary hypertension.
    Morrell NW; Morris KG; Stenmark KR
    Am J Physiol; 1995 Oct; 269(4 Pt 2):H1186-94. PubMed ID: 7485548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Perspectives for angiotensin profiling with liquid chromatography/mass spectrometry to evaluate ACE/ACE2 balance in endothelial dysfunction and vascular pathologies.
    Olkowicz M; Chlopicki S; Smolenski RT
    Pharmacol Rep; 2015 Aug; 67(4):778-85. PubMed ID: 26321281
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin converting enzyme 2 and angiotensin (1-7) axis in pulmonary arterial hypertension.
    Sandoval J; Del Valle-Mondragón L; Masso F; Zayas N; Pulido T; Teijeiro R; Gonzalez-Pacheco H; Olmedo-Ocampo R; Sisniega C; Paez-Arenas A; Pastelin-Hernandez G; Gomez-Arroyo J; Voelkel NF
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32241831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A potential therapeutic role for angiotensin-converting enzyme 2 in human pulmonary arterial hypertension.
    Hemnes AR; Rathinasabapathy A; Austin EA; Brittain EL; Carrier EJ; Chen X; Fessel JP; Fike CD; Fong P; Fortune N; Gerszten RE; Johnson JA; Kaplowitz M; Newman JH; Piana R; Pugh ME; Rice TW; Robbins IM; Wheeler L; Yu C; Loyd JE; West J
    Eur Respir J; 2018 Jun; 51(6):. PubMed ID: 29903860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. ACE2 (Angiotensin-Converting Enzyme 2) in Cardiopulmonary Diseases: Ramifications for the Control of SARS-CoV-2.
    Sharma RK; Stevens BR; Obukhov AG; Grant MB; Oudit GY; Li Q; Richards EM; Pepine CJ; Raizada MK
    Hypertension; 2020 Sep; 76(3):651-661. PubMed ID: 32783758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrapulmonary activation of the angiotensin-converting enzyme type 2/angiotensin 1-7/G-protein-coupled Mas receptor axis attenuates pulmonary hypertension in Ren-2 transgenic rats exposed to chronic hypoxia.
    Hampl V; Herget J; Bíbová J; Baňasová A; Husková Z; Vaňourková Z; Jíchová Š; Kujal P; Vernerová Z; Sadowski J; Červenka L
    Physiol Res; 2015; 64(1):25-38. PubMed ID: 25194138
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Angiotensin-converting enzyme 2 attenuates oxidative stress and VSMC proliferation via the JAK2/STAT3/SOCS3 and profilin-1/MAPK signaling pathways.
    Song B; Jin H; Yu X; Zhang Z; Yu H; Ye J; Xu Y; Zhou T; Oudit GY; Ye JY; Chen C; Gao P; Zhu D; Penninger JM; Zhong JC
    Regul Pept; 2013 Aug; 185():44-51. PubMed ID: 23816468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeting the renin-angiotensin system as novel therapeutic strategy for pulmonary diseases.
    Tan WSD; Liao W; Zhou S; Mei D; Wong WF
    Curr Opin Pharmacol; 2018 Jun; 40():9-17. PubMed ID: 29288933
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of the renin-angiotensin system in the development of insulin resistance in skeletal muscle.
    Henriksen EJ; Prasannarong M
    Mol Cell Endocrinol; 2013 Sep; 378(1-2):15-22. PubMed ID: 22564510
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Angiotensin converting enzyme 2 and its emerging role in the regulation of the renin angiotensin system].
    Soler MJ; Lloveras J; Batlle D
    Med Clin (Barc); 2008 Jul; 131(6):230-6. PubMed ID: 18674503
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liver disease and the renin-angiotensin system: recent discoveries and clinical implications.
    Lubel JS; Herath CB; Burrell LM; Angus PW
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1327-38. PubMed ID: 18557800
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Renin-Angiotensin System: An Important Player in the Pathogenesis of Acute Respiratory Distress Syndrome.
    Hrenak J; Simko F
    Int J Mol Sci; 2020 Oct; 21(21):. PubMed ID: 33126657
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation of renin-angiotensin-aldosterone system (RAAS) in the lung of smoking-induced pulmonary arterial hypertension (PAH) rats.
    Yuan YM; Luo L; Guo Z; Yang M; Ye RS; Luo C
    J Renin Angiotensin Aldosterone Syst; 2015 Jun; 16(2):249-53. PubMed ID: 25795458
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention.
    Ahmadian E; Pennefather PS; Eftekhari A; Heidari R; Eghbal MA
    Expert Rev Gastroenterol Hepatol; 2016 Nov; 10(11):1279-1288. PubMed ID: 27352778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Renin-angiotensin system revisited.
    Fyhrquist F; Saijonmaa O
    J Intern Med; 2008 Sep; 264(3):224-36. PubMed ID: 18793332
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intrarenal alterations of the angiotensin-converting enzyme type 2/angiotensin 1-7 complex of the renin-angiotensin system do not alter the course of malignant hypertension in Cyp1a1-Ren-2 transgenic rats.
    Husková Z; Kopkan L; Červenková L; Doleželová Š; Vaňourková Z; Škaroupková P; Nishiyama A; Kompanowska-Jezierska E; Sadowski J; Kramer HJ; Červenka L
    Clin Exp Pharmacol Physiol; 2016 Apr; 43(4):438-49. PubMed ID: 26833491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Angiotensin-converting enzyme 2 activation suppresses pulmonary vascular remodeling by inducing apoptosis through the Hippo signaling pathway in rats with pulmonary arterial hypertension.
    Yan D; Li G; Zhang Y; Liu Y
    Clin Exp Hypertens; 2019; 41(6):589-598. PubMed ID: 30806090
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.